Do You Pay Monthly for Private Medical Cannabis in the UK?

With increasing public interest around medical cannabis, many patients in the UK are exploring private routes to access this treatment. Yet, alongside the excitement, confusion abounds—particularly around the ongoing monthly cost, how follow-up appointments work, and the transparency of prescription pricing. In this post, we clarify key points about private medical cannabis access in the UK, separating legality from availability, explaining who can prescribe, and outlining crucial regulatory requirements.
Legality Versus Real-World Access
Since November 2018, medical cannabis has been legal in the UK when prescribed by specialist doctors under defined circumstances. However, legal does not mean easily accessible. The National Health Service (NHS) currently restricts funding to very limited cases, pushing many patients to explore private prescriptions.
Legal framework: Cannabis-based products for medicinal use are controlled medicines. Doctors must prescribe from the Specialist Register maintained by the General Medical Council (GMC). Real-world access: The NHS approval rate for cannabis prescriptions is extremely low, prompting a growth in private clinics offering consultations and prescriptions.
This discrepancy means patients often face a significant financial commitment for ongoing access.
The NHS Funding Gap and the Private Market Reality
NHS guidelines limit cannabis prescriptions to highly specific cases such as certain epilepsy syndromes, chemotherapy-induced nausea, or multiple sclerosis spasticity when other medications have failed. For most patients seeking symptom relief—chronic pain, anxiety, or other conditions—NHS funding is not an option.

Consequently, the private market has stepped in, but it comes at a price:
Private consultations can cost upwards of £150 - £300 per appointment. Follow-up appointments—required to monitor treatment response—may be charged similarly and are typically scheduled monthly or every few months depending on patient need. Repeat prescriptions for cannabis-based products also add an ongoing monthly or quarterly cost.
This leads to a substantial ongoing monthly cost for patients outside the NHS framework, often reaching several hundred pounds per month once consultation fees, prescription fees, and product costs are combined.
Common Marketing Mistake: Lack of Transparent Pricing
One critical issue is the failure by many private clinics and online pharmacies to clearly state prices upfront. Many advert platforms only advertise initial consultation costs, neglecting to disclose that:
Follow-up appointment fees will apply regularly Prescription costs vary widely depending on the type, dosage, and quantity of cannabis product prescribed Patients may need multiple prescriptions each month, depending on supply limits and product form (oils, capsules, flowers)
Without transparent pricing for ongoing monthly costs including prescriptions, patients can find themselves unprepared for the financial commitment.
Who Can Prescribe Medical Cannabis in the UK?
Only doctors registered on the GMC’s Specialist Register are legally allowed to prescribe medical cannabis. This is emphasised by the strict nature of these medicines and the need for specialist oversight.
General practitioners (GPs) cannot prescribe medical cannabis unless they are also on the Specialist Register. This policy helps ensure prescriptions come from clinicians with appropriate expertise in complex conditions. Many private clinics employ or collaborate with these specialists to offer cannabis prescriptions safely and legally. Video Consultations and Remote Prescribing
The rise of telemedicine has transformed how private medical cannabis patients consult with doctors. Video consultations are increasingly common, allowing accessibility across the UK without travel.

However, in England, any service offering remote prescribing—including video consultations—must be registered with and declared to the Care Quality Commission (CQC). This ensures oversight of safety and compliance.
Registration with the CQC is mandatory for clinics conducting remote consultations and prescribing controlled drugs like medical cannabis. The CQC monitors standard adherence including patient consent, data protection, and prescribing protocols. Patients should verify that their chosen provider is CQC registered to ensure legitimacy. Regulation and CQC Oversight in England
Private medical cannabis clinics in England are regulated as healthcare providers under the CQC. This covers:
Safety: Ensuring all prescribing and dispensing practices meet legal standards. Effectiveness: Clinics must have qualified staff and proper clinical governance. Communication: Transparency about pricing, treatment expectations, and follow-up protocols. Responsiveness: Handling patient feedback and complaints effectively.
Outside England, regulation varies:
Nation Regulator Notes Scotland Healthcare Improvement Scotland Oversees private healthcare but no direct equivalent to CQC for remote prescribing. Wales Healthcare Inspectorate Wales Regulation similar to England but CQC registration does not extend here. Northern Ireland Regulation and Quality Improvement Authority Runs independent monitoring of private providers. Checklist to Evaluate Private Medical Cannabis Costs
Before committing to private medical cannabis treatment, consider this checklist to avoid hidden costs and unclear pricing:
Are initial consultation fees stated clearly? Look for full pricing details. Is the cost of follow-up appointments disclosed? As ongoing monitoring is vital, these add to monthly expenses. Does the clinic provide transparent information on prescription costs? Including dosage, quantity limits, and refill timing. Is the prescribing doctor GMC Specialist registered? Confirm legitimacy. Is the private provider registered with the CQC (if in England) or equivalent regulatory body? Ensures oversight and safety. Does the clinic explain the expected ongoing monthly cost, combining consultation and product fees? Summary
While medical cannabis is legal in the UK, real-world access via the NHS remains limited, pushing many patients towards private prescriptions. This often involves substantial Browse around this site https://bizzmarkblog.com/how-can-i-compare-providers-like-releaf-cannabis-with-other-clinics/ ongoing monthly costs that include multiple consultations, permit repeat prescriptions, and payment for the cannabis products themselves.

Private providers typically use video consultations and remote Check out the post right here https://smoothdecorator.com/why-are-patient-registries-important-in-uk-medical-cannabis-care/ prescribing, but in England these clinics must be registered with the CQC. Prescribers must be on the GMC Specialist Register to remain compliant.

Patients should be wary of marketing claims that omit full cost details. Transparency about consultation, follow-up appointment fees, and prescription pricing is critical to making an informed decision.

By understanding the complex interplay of legality, regulation, and private market realities, patients can better navigate private medical cannabis access in the UK with eyes wide open.